ArticleCancer research and treatment2023

ARID1A Mutation from Targeted Next-Generation Sequencing Predicts Primary Resistance to Gemcitabine and Cisplatin Chemotherapy in Advanced Biliary Tract Cancer.

Sung Hwan Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.